Overview of the treatment of binge eating disorder.

Abstract

We performed a qualitative review of treatment studies of binge eating disorder (BED), focusing on randomized clinical trials (RCTs). Limited effectiveness has been demonstrated for self-help strategies, and substantial effectiveness has been shown for cognitive behavioral therapy (CBT) and interpersonal therapy (IPT). CBT and IPT may each be more effective than behavior weight loss therapy (BWLT) for reducing binge eating over the long term. The stimulant pro-drug lisdexamfetamine dimesylate (LDX) is the only drug approved by the FDA for the treatment of BED in adults based on 2 pivotal RCTs. Topiramate also decreases binge eating behavior, but its use is limited by its adverse event profile. Antidepressants may be modestly effective over the short term for reducing binge eating behavior and comorbid depressive symptoms, but are not associated with clinically significant weight loss. A RCT presented in abstract form suggests that intranasal naloxone may decrease time spent binge eating. There is no RCT of obesity surgery in BED, but many patients with BED seek and receive such surgery. While some studies suggest patients with BED and obesity do just as well as patients with obesity alone, other studies suggest that patients with BED have more post-operative complications, less weight loss, and more weight regain. This evidence suggests that patients with BED would benefit from receiving highly individualized treatment.

• Authors: Susan L McElroy, Anna I Guerdjikova, Nicole Mori, Maura R Munoz, Paul E Keck
• Journal: CNS spectrums (CNS Spectr) Vol. 20 Issue 6 Pg. 546-56 (Dec 2015) ISSN: 1092-8529 [Print] United States
• PMID: 26594849 (Publication Type: Journal Article, Review)

Topics

• Binge-Eating Disorder (therapy)
• Humans
• Randomized Controlled Trials as Topic